hydromorphone and buprenorphine

hydromorphone has been researched along with buprenorphine in 70 studies

Research

Studies (70)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (15.71)	18.7374
1990's	11 (15.71)	18.2507
2000's	16 (22.86)	29.6817
2010's	22 (31.43)	24.3611
2020's	10 (14.29)	2.80

Authors

Authors	Studies
Bigelow, GE; Liebson, IA; Preston, KL; Strain, EC	1
Fudala, PJ; Johnson, RE	1
Bigelow, GE; Liebson, I; Preston, KL; Strain, EC	1
Bigelow, GE; Liebson, IA; Preston, KL	2
Bickel, WK; Bigelow, GE; Jasinski, DR; Johnson, RE; Liebson, IA; Stitzer, ML	2
Bickel, W; Bigelow, G; Liebson, I; Preston, K	1
Foley, KM; Houde, RW; Inturrisi, CE; Moulin, DE; Nip, TJ; Reidenberg, B; Wallenstein, S; Weinberg, DS	1
Bickel, WK; Bigelow, GE; Liebson, IA; Preston, KL	1
Bree, MP; Mello, NK; Mendelson, JH	2
France, CP; Jacobson, AE; Woods, JH	2
Kosten, TR; McMahon, TJ; Pearsall, HR; Price, LH; Rosen, MI; Wallace, EA; Woods, SW	1
Bigelow, GE; Preston, KL	1
Bigelow, GE; Preston, KL; Stitzer, ML; Walsh, SL	1
Bigelow, GE; Garner, JE; Preston, KL; Sullivan, JT; Walsh, SL	1
Bigelow, GE; Liebson, IA; Preston, KL; Strain, EC; Walsh, SL	1
Bigelow, GE; Jones, HE; Preston, KL	1
Schuh, KJ; Stitzer, ML; Walsh, SL	1
Greenwald, MK; Johanson, CE; Schuster, CR	1
Bigelow, GE; Stoller, K; Strain, EC; Walsh, SL	1
Bigelow, GE; Stoller, KB; Strain, EC; Walsh, SL	1
Bigelow, GE; Strain, EC; Walsh, SL	1
Rattan, AK; Tejwani, GA	1
Bertin, P; Bonnet, C; Coyral, D; Grilo, RM; Scotto di Fazano, C; Treves, R; Vergne, P	1
Husbands, SM; Lewis, JW	1
Bigelow, GE; Johnson, RE; Kerrigan, JH; Liebson, IA; Nuwayser, ES; Sigmon, SC; Sobel, BF; Walsh, SL	1
Lindena, G; Müller-Busch, HC; Tietze, K; Woskanjan, S	1
Greenwald, MK; Hursh, SR	1
Bueller, J; Chang, Y; Greenwald, M; Johanson, CE; Kilbourn, M; Koeppe, R; Moody, DE; Zubieta, JK	1
Bigelow, GE; Correia, CJ; Strain, EC; Walsh, SL	1
Niedfeldt, RL; Robertson, SA	1
Bigelow, GE; Harrison, JA; Lanier, RK; Nuwayser, ES; Umbricht, A	1
Bailey, JE; Campagna, E; Dart, RC	1
Kloecker, N; Mueller, M; Nadstawek, J; Schaefer, N; Schenk, M; Schroeck, A; Standop, J; Wirz, S; Wittmann, M	1
Anderson, BJ; Craig, F; Michel, E; Zernikow, B	1
Carter, JE; Levine, JF; Pavuk, AA; Posner, LP; Rokshar, JL	1
Greenwald, MK	1
Bigelow, GE; Correia, CJ; Duke, AN; Strain, EC; Walsh, SL	1
Greenwald, MK; Lundahl, LH; Steinmiller, CL	1
Austin, BR; Barletta, M; Ko, JC; Krimins, RA; Payton, ME; Weil, AB	1
Baker, BB; Johnson, SM; Lahner, LL; Mans, C; Sladky, KK	1
Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I	1
Chang-Chien, GC; Chu, SK; Joseph, P; McCormick, Z	1
Christensen, C; Gupta, D; Soskin, V	1
Bernardy, K; Häuser, W; Maier, C	1
Duse, G; Ferrari, R; Visentin, M; Zanolin, ME	1
Ambros, B	1
Fudala, PJ; Greenwald, MK; Heidbreder, C; Jones, JP; Liu, Y; Nasser, AF; Twumasi-Ankrah, P; Vince, B	1
Lizarraga, I; Monteiro, BP; Simon, BT; Steagall, PV; Troncy, E	1
Coe, MA; Comer, SD; Jones, JD; Kelsh, D; Kim, S; Levy-Cooperman, N; Lofwall, MR; Nuzzo, PA; Sheldon, B; Tiberg, F; Vince, B; Walsh, SL	1
Bell, RF; Derry, S; Moore, RA; Wee, B; Wiffen, PJ	1
Holland, TL; Neuss, MJ	1
Bayer, O; Heid, F; Laufenberg-Feldmann, R; Schuster, M	1
Behm, B; Davis, MP; Fernandez, C; McPherson, ML; Mehta, Z	1
Guevara, M; Hofilena, D; Mikel, C; West, R	1
Bigelow, GE; Edwards, RR; Huhn, AS; Smith, MT; Strain, EC; Tompkins, DA	1
Brás, M; Fragoso, M; Vieira, C	1
Dember, LM; Jhamb, M; Liebschutz, J; Roy, PJ; Weltman, M	1
Balasanova, AA; Crum, IT; Meyer Karre, VM	1
Monteiro, BP; Moreno, KL; Scallan, EM; Simon, BT; Steagall, PV	1
Beck, O; Böttcher, M; Keller, T; Lierheimer, S; Monticelli, FC	1
Eidbo, SA; Hagedorn, JD; Kaufman, DE; Kropp Lopez, AK; Mathew, V; McCall, KL; Nichols, SD; Piper, BJ	1
Coulter, C; Garnier, M; Moore, C	1
Bozinoff, N; Le Foll, B; Rubin-Kahana, DS; Tardelli, VS	1
Ciotti-McClallen, M; Costa, RS; Maki, L; Perry, S; Starks, D; Stein, AB; Tilley, R	1
Caputo, A; Christopher, C; Compton, P; Delgado, MK; Lowenstein, M; McFadden, R; Olenik, JM; Perrone, J; Ronning, K; Sigueza, AL; Thakrar, AP; Uritsky, TJ; Winston, A	1
Ambros, B; Crookes, A; Desprez, I; Di Girolamo, N	1

Reviews

8 review(s) available for hydromorphone and buprenorphine

Article	Year
Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse. Mini reviews in medicinal chemistry, 2003, Volume: 3, Issue:2 Topics: Analgesics, Opioid; Animals; Buprenorphine; Drug Evaluation, Preclinical; Etorphine; Humans; Hydromorphone; Ligands; Morphinans; Narcotic Antagonists; Receptors, Opioid, mu; Structure-Activity Relationship; Substance-Related Disorders	2003
Pediatric palliative care: use of opioids for the management of pain. Paediatric drugs, 2009, Volume: 11, Issue:2 Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Child; Delayed-Action Preparations; Fentanyl; Humans; Hydromorphone; Methadone; Morphine; Narcotics; Pain; Palliative Care	2009
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]. Schmerz (Berlin, Germany), 2015, Volume: 29, Issue:1 Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Hydromorphone; Long-Term Care; Morphine; Oxycodone; Oxymorphone; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Tapentadol; Tramadol; Treatment Outcome	2015
Opioids for cancer pain - an overview of Cochrane reviews. The Cochrane database of systematic reviews, 2017, 07-06, Volume: 7 Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Fentanyl; Humans; Hydromorphone; Methadone; Oxycodone; Phenols; Review Literature as Topic; Tapentadol; Tramadol	2017
Opioid Rotation in Cancer Pain Treatment. Deutsches Arzteblatt international, 2018, 03-02, Volume: 115, Issue:9 Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Chronic Pain; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain Management	2018
What Parenteral Opioids to Use in Face of Shortages of Morphine, Hydromorphone, and Fentanyl. The American journal of hospice & palliative care, 2018, Volume: 35, Issue:8 Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Hydromorphone; Morphine; Nalbuphine; Pain	2018
[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review]. Acta medica portuguesa, 2019, May-31, Volume: 32, Issue:5 Topics: Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Deglutition Disorders; Fentanyl; Humans; Hydromorphone; Liver Failure; Morphine; Oxycodone; Renal Dialysis; Renal Insufficiency; Tapentadol; Tramadol	2019
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review. Harm reduction journal, 2022, 10-13, Volume: 19, Issue:1 Topics: Analgesics, Opioid; Buprenorphine; Heroin; Humans; Hydromorphone; Opiate Substitution Treatment; Opioid-Related Disorders	2022

Trials

32 trial(s) available for hydromorphone and buprenorphine

Article	Year
Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:3 Topics: Adult; Buprenorphine; Cognition; Drug Interactions; Hemodynamics; Humans; Hydromorphone; Injections, Intramuscular; Male; Methadone; Naloxone; Psychomotor Performance; Substance Abuse Treatment Centers; Substance-Related Disorders	1992
Development of buprenorphine for the treatment of opioid dependence. NIDA research monograph, 1992, Volume: 121 Topics: Adult; Buprenorphine; Double-Blind Method; Female; Follow-Up Studies; Heroin Dependence; Humans; Hydromorphone; Male; Middle Aged; Naloxone; Substance Withdrawal Syndrome; Testosterone	1992
A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties. NIDA research monograph, 1987, Volume: 76 Topics: Adult; Analysis of Variance; Buprenorphine; Clinical Trials as Topic; Heroin Dependence; Humans; Hydromorphone; Male; Methadone; Narcotic Antagonists; Substance Withdrawal Syndrome	1987
Buprenorphine and naloxone alone and in combination in opioid-dependent humans. Psychopharmacology, 1988, Volume: 94, Issue:4 Topics: Adult; Blood Pressure; Body Temperature; Buprenorphine; Cognition; Heart Rate; Humans; Hydromorphone; Male; Naloxone; Opioid-Related Disorders; Psychomotor Performance; Respiration; Substance Withdrawal Syndrome	1988
Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug and alcohol dependence, 1994, Volume: 35, Issue:2 Topics: Administration, Sublingual; Adult; Buprenorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Neurologic Examination; Opioid-Related Disorders; Single-Blind Method; Substance Withdrawal Syndrome; Time Factors	1994
Acute administration of buprenorphine in humans: partial agonist and blockade effects. The Journal of pharmacology and experimental therapeutics, 1995, Volume: 274, Issue:1 Topics: Adult; Buprenorphine; Cross-Over Studies; Double-Blind Method; Humans; Hydromorphone; Male; Methadone; Narcotic Antagonists; Receptors, Opioid; Respiration	1995
Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:2 Topics: Adult; Buprenorphine; Cocaine; Cross-Over Studies; Double-Blind Method; Drug Interactions; Humans; Hydromorphone; Liver; Male; Naltrexone; Narcotic Antagonists; Narcotics; Respiration; Substance-Related Disorders	1996
The effects of buprenorphine in buprenorphine-maintained volunteers. Psychopharmacology, 1997, Volume: 129, Issue:4 Topics: Adult; Buprenorphine; Female; Humans; Hydromorphone; Male; Neuropsychological Tests; Substance-Related Disorders	1997
Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans. Psychopharmacology, 1999, Volume: 145, Issue:2 Topics: Adult; Buprenorphine; Cross-Over Studies; Double-Blind Method; Humans; Hydromorphone; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Time Factors	1999
Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance. Drug and alcohol dependence, 1999, Oct-01, Volume: 56, Issue:3 Topics: Adult; Analysis of Variance; Behavior, Addictive; Buprenorphine; Double-Blind Method; Drug Synergism; Female; Heroin Dependence; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Narcotics; Outpatients; Pupil; Reinforcement, Psychology; Surveys and Questionnaires	1999
Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacology, 2000, Volume: 148, Issue:4 Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Buprenorphine; Drug Combinations; Humans; Hydromorphone; Injections, Intravenous; Male; Middle Aged; Motor Activity; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Tablets; Time Factors	2000
Effects of buprenorphine/naloxone in opioid-dependent humans. Psychopharmacology, 2001, Volume: 154, Issue:3 Topics: Administration, Sublingual; Adolescent; Adult; Affect; Buprenorphine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydromorphone; Injections, Intramuscular; Male; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Observer Variation; Opioid-Related Disorders; Psychomotor Performance; Substance Withdrawal Syndrome	2001
Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine. Psychopharmacology, 2002, Volume: 159, Issue:2 Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydromorphone; Male; Naloxone; Narcotic Antagonists; Opioid-Related Disorders	2002
Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification. Drug and alcohol dependence, 2004, Jan-07, Volume: 73, Issue:1 Topics: Administration, Oral; Adult; Ambulatory Care; Buprenorphine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heroin Dependence; Humans; Hydromorphone; Injections, Subcutaneous; Male; Metabolic Clearance Rate; Narcotics; Neurologic Examination; Patient Acceptance of Health Care; Rehabilitation Centers; Substance Withdrawal Syndrome	2004
Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply. Drug and alcohol dependence, 2006, Oct-15, Volume: 85, Issue:1 Topics: Adolescent; Adult; Behavior, Addictive; Buprenorphine; Choice Behavior; Commerce; Costs and Cost Analysis; Drug Administration Schedule; Female; Heroin Dependence; Humans; Hydromorphone; Male; Middle Aged; Narcotics; Opioid-Related Disorders; Urinalysis	2006
Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. Biological psychiatry, 2007, Jan-01, Volume: 61, Issue:1 Topics: Adult; Analgesics, Opioid; Area Under Curve; Brain; Brain Mapping; Buprenorphine; Double-Blind Method; Drug Administration Schedule; Female; Fentanyl; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Positron-Emission Tomography; Receptors, Opioid, mu; Respiration; Time Factors; Tritium	2007
Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period. Psychopharmacology, 2006, Volume: 189, Issue:3 Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hydromorphone; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome	2006
Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. European journal of pain (London, England), 2009, Volume: 13, Issue:7 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Buprenorphine; Cohort Studies; Constipation; Delayed-Action Preparations; Female; Fentanyl; Gastrointestinal Diseases; Humans; Hydromorphone; Laxatives; Male; Middle Aged; Nausea; Neoplasms; Pain, Intractable; Prospective Studies; Vomiting	2009
Effects of opioids and anesthetic drugs on body temperature in cats. Veterinary anaesthesia and analgesia, 2010, Volume: 37, Issue:1 Topics: Analgesics, Opioid; Anesthetics; Anesthetics, Combined; Anesthetics, Inhalation; Animals; Body Temperature; Buprenorphine; Cats; Cross-Over Studies; Female; Hydromorphone; Isoflurane; Ketamine; Male; Malignant Hyperthermia; Morphine	2010
Effects of experimental Unemployment, Employment and Punishment analogs on opioid seeking and consumption in heroin-dependent volunteers. Drug and alcohol dependence, 2010, Sep-01, Volume: 111, Issue:1-2 Topics: Adult; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Choice Behavior; Double-Blind Method; Drug-Seeking Behavior; Employment; Female; Games, Experimental; Heroin Dependence; Humans; Hydromorphone; Male; Middle Aged; Narcotics; Punishment; Reinforcement, Psychology	2010
Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers. Psychopharmacology, 2010, Volume: 211, Issue:3 Topics: Administration, Sublingual; Adult; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Users; Female; Humans; Hydromorphone; Injections, Intramuscular; Male; Middle Aged; Naloxone; Opioid-Related Disorders; Surveys and Questionnaires	2010
Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:13 Topics: Adolescent; Adult; Buprenorphine; Choice Behavior; Cocaine; Cocaine-Related Disorders; Delayed-Action Preparations; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Seeking Behavior; Female; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Reinforcement Schedule; Reward; Substance Withdrawal Syndrome	2010
Evaluation of dexmedetomidine and ketamine in combination with various opioids as injectable anesthetic combinations for castration in cats. Journal of the American Veterinary Medical Association, 2011, Dec-01, Volume: 239, Issue:11 Topics: Anesthesia Recovery Period; Anesthesia, Intravenous; Anesthetics, Combined; Animals; Blood Pressure; Buprenorphine; Butorphanol; Cats; Dexmedetomidine; Heart Rate; Hydromorphone; Ketamine; Male; Orchiectomy	2011
Antinociceptive efficacy of buprenorphine and hydromorphone in red-eared slider turtles (Trachemys scripta elegans). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2012, Volume: 43, Issue:3 Topics: Animals; Buprenorphine; Cross-Over Studies; Dose-Response Relationship, Drug; Hot Temperature; Hydromorphone; Pain; Time Factors; Turtles	2012
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study. Advances in therapy, 2013, Volume: 30, Issue:3 Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol	2013
Effect of pretreatment with hydromorphone or buprenorphine on thermal antinociception induced by fentanyl in awake cats. Journal of feline medicine and surgery, 2016, Volume: 18, Issue:10 Topics: Analgesics; Animals; Body Temperature; Buprenorphine; Cats; Cross-Over Studies; Drug Administration Schedule; Female; Fentanyl; Hydromorphone; Infusions, Intravenous; Male	2016
Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder. Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:1 Topics: Adult; Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydromorphone; Injections, Intramuscular; Injections, Subcutaneous; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Young Adult	2016
Antinociceptive effects of intravenous administration of hydromorphone hydrochloride alone or followed by buprenorphine hydrochloride or butorphanol tartrate to healthy conscious cats. American journal of veterinary research, 2016, Volume: 77, Issue:3 Topics: Analgesics, Opioid; Animals; Buprenorphine; Cats; Cross-Over Studies; Double-Blind Method; Female; Hydromorphone; Injections, Intravenous; Male; Nociceptors; Pain Measurement; Skin Temperature	2016
Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial. JAMA psychiatry, 2017, 09-01, Volume: 74, Issue:9 Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult	2017
Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals. Anesthesiology, 2019, Volume: 130, Issue:1 Topics: Adult; Analgesia; Analgesics, Opioid; Buprenorphine; Double-Blind Method; Female; Humans; Hydromorphone; Male; Opioid-Related Disorders; Pain; Treatment Outcome	2019
Intramuscular alfaxalone with or without buprenorphine or hydromorphone provides sedation with minimal adverse effects in healthy rabbits (Oryctolagus cuniculus) in a randomized blinded controlled trial. Journal of the American Veterinary Medical Association, 2022, 12-15, Volume: 261, Issue:2 Topics: Anesthesia; Animals; Buprenorphine; Hydromorphone; Hypnotics and Sedatives; Injections, Intramuscular; Male; Pregnanediones; Rabbits	2022
Subcutaneous administration of hydromorphone (0.2 mg/kg) provides antinociception in ferrets (Mustela putorius furo). American journal of veterinary research, 2023, Sep-01, Volume: 84, Issue:10 Topics: Analgesics, Opioid; Anesthesia; Animals; Buprenorphine; Cross-Over Studies; Female; Ferrets; Hydromorphone; Male	2023

Other Studies

30 other study(ies) available for hydromorphone and buprenorphine

Article	Year
The effects of buprenorphine in methadone-dependent volunteers. NIDA research monograph, 1990, Volume: 105 Topics: Buprenorphine; Double-Blind Method; Humans; Hydromorphone; Male; Methadone; Naloxone; Opioid-Related Disorders; Pupil	1990
Abuse liability assessment of buprenorphine-naloxone combinations. NIDA research monograph, 1987, Volume: 76 Topics: Blood Pressure; Buprenorphine; Drug Combinations; Heart Rate; Humans; Hydromorphone; Male; Naloxone; Pupil; Respiration; Skin Temperature; Substance-Related Disorders; Surveys and Questionnaires	1987
Drug discrimination in human post-addicts: agonist/antagonist opioids. NIDA research monograph, 1988, Volume: 81 Topics: Buprenorphine; Butorphanol; Discrimination Learning; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pentazocine	1988
Sublingual absorption of selected opioid analgesics. Clinical pharmacology and therapeutics, 1988, Volume: 44, Issue:3 Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Analysis of Variance; Biological Availability; Buprenorphine; Fentanyl; Heroin; Humans; Hydromorphone; Levorphanol; Methadone; Morphine; Mouth; Naloxone; Oxycodone; Time Factors	1988
Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:1 Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pupil; Respiration	1988
Drug discrimination in human postaddicts: agonist-antagonist opioids. The Journal of pharmacology and experimental therapeutics, 1989, Volume: 250, Issue:1 Topics: Adult; Buprenorphine; Butorphanol; Conditioning, Operant; Discrimination, Psychological; Humans; Hydromorphone; Male; Nalbuphine; Pentazocine; Pupil; Substance-Related Disorders	1989
Comparison of the effects of buprenorphine and methadone on opiate self-administration in primates. NIDA research monograph, 1982, Volume: 41 Topics: Animals; Buprenorphine; Dose-Response Relationship, Drug; Eating; Heroin Dependence; Humans; Hydromorphone; Macaca mulatta; Macaca nemestrina; Male; Methadone; Morphinans; Opioid-Related Disorders; Self Administration	1982
Comparison of buprenorphine and methadone effects on opiate self-administration in primates. The Journal of pharmacology and experimental therapeutics, 1983, Volume: 225, Issue:2 Topics: Animals; Buprenorphine; Depression, Chemical; Disease Models, Animal; Feeding Behavior; Heroin; Humans; Hydromorphone; Macaca mulatta; Macaca nemestrina; Methadone; Morphinans; Opioid-Related Disorders; Self Administration	1983
Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine. The Journal of pharmacology and experimental therapeutics, 1984, Volume: 230, Issue:3 Topics: Animals; Buprenorphine; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Hydromorphone; Morphinans; Morphine; Naltrexone; Oxymorphone; Time Factors	1984
Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine. NIDA research monograph, 1984, Volume: 49 Topics: Animals; Buprenorphine; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Hydromorphone; Mice; Morphinans; Morphine; Naltrexone; Nociceptors; Oxymorphone	1984
Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:1 Topics: Adult; Buprenorphine; Butorphanol; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Psychological; Humans; Hydromorphone; Male; Nalbuphine; Pentazocine; Psychomotor Performance	1994
Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:3 Topics: Adult; Blood Pressure; Buprenorphine; Butorphanol; Choice Behavior; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Hydromorphone; Injections, Intramuscular; Male; Nalbuphine; Pentazocine; Psychomotor Performance; Surveys and Questionnaires	1999
The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat. Anesthesia and analgesia, 2002, Volume: 94, Issue:6 Topics: Analgesics, Opioid; Animals; Binding, Competitive; Buprenorphine; Dose-Response Relationship, Drug; Hydromorphone; Ligands; Male; Pain Measurement; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spinal Cord	2002
Opioid rotation in the treatment of joint pain. A review of 67 cases. Joint bone spine, 2002, Volume: 69, Issue:5 Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Drug Administration Schedule; Fentanyl; Humans; Hydromorphone; Joints; Morphine; Pain; Pain Measurement; Retrospective Studies; Rheumatic Diseases; Rheumatology; Treatment Outcome	2002
Opioid switch in palliative care, opioid choice by clinical need and opioid availability. European journal of pain (London, England), 2005, Volume: 9, Issue:5 Topics: Aged; Ambulatory Care Facilities; Analgesics, Opioid; Buprenorphine; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization Review; Female; Fentanyl; Hospitals; Humans; Hydromorphone; Male; Middle Aged; Morphine; Oxycodone; Pain; Palliative Care; Prospective Studies; Treatment Outcome	2005
Postanesthetic hyperthermia in cats: a retrospective comparison between hydromorphone and buprenorphine. Veterinary anaesthesia and analgesia, 2006, Volume: 33, Issue:6 Topics: Analgesics, Opioid; Anesthesia Recovery Period; Animals; Body Temperature; Buprenorphine; Cat Diseases; Cats; Female; Fever; Florida; Hydromorphone; Intraoperative Care; Male; Postoperative Care; Prevalence; Records; Retrospective Studies	2006
Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation. Psychopharmacology, 2008, Volume: 198, Issue:2 Topics: Administration, Cutaneous; Adult; Area Under Curve; Buprenorphine; Chemistry, Pharmaceutical; Female; Humans; Hydromorphone; Male; Middle Aged; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome	2008
The underrecognized toll of prescription opioid abuse on young children. Annals of emergency medicine, 2009, Volume: 53, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Buprenorphine; Child, Preschool; Female; Humans; Hydrocodone; Hydromorphone; Infant; Infant, Newborn; Male; Methadone; Morphine; Oxycodone; Poisoning; Prescription Drugs; United States	2009
Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review. Pain medicine (Malden, Mass.), 2013, Volume: 14, Issue:8 Topics: Acetaminophen; Acute Pain; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesics, Opioid; Buprenorphine; Compartment Syndromes; Creatine Kinase; Drug Combinations; Glycogen Storage Disease Type V; Humans; Hydromorphone; Injections, Intramuscular; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Pain Measurement; Rhabdomyolysis	2013
Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients? Middle East journal of anaesthesiology, 2013, Volume: 22, Issue:3 Topics: Acetaminophen; Adolescent; Adult; Analgesia, Obstetrical; Analgesics, Opioid; Buprenorphine; Cesarean Section; Delivery, Obstetric; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Hyperalgesia; Ibuprofen; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies; Young Adult	2013
Effectiveness of opioid analgesics in chronic noncancer pain. Pain practice : the official journal of World Institute of Pain, 2015, Volume: 15, Issue:3 Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Fentanyl; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Opioid-Related Disorders; Oxycodone; Pain Clinics; Pain Measurement; Personality; Phenols; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tapentadol; Treatment Outcome	2015
Digital ischaemia after intra-arterial drug injection. BMJ case reports, 2017, Sep-25, Volume: 2017 Topics: Buprenorphine; Constriction, Pathologic; Fingers; Humans; Hydromorphone; Injections, Intra-Arterial; Ischemia; Male; Middle Aged; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Peripheral Vascular Diseases; Toes	2017
Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS. Drug and alcohol dependence, 2018, 12-01, Volume: 193 Topics: Buprenorphine; Cannabinoids; Chromatography, Liquid; Humans; Hydrocodone; Hydromorphone; Illicit Drugs; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Oxymorphone; Retrospective Studies; Saliva; Substance Abuse Detection; Tandem Mass Spectrometry	2018
Pain management in patients with chronic kidney disease and end-stage kidney disease. Current opinion in nephrology and hypertension, 2020, Volume: 29, Issue:6 Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Hydromorphone; Kidney Failure, Chronic; Oxycodone; Pain; Pain Management; Receptors, Opioid, mu; Renal Insufficiency, Chronic	2020
Transitioning From Intrathecal Hydromorphone to Sublingual Buprenorphine-Naloxone Through Microdosing: A Case Report. A&A practice, 2020, Volume: 14, Issue:11 Topics: Aged; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Chronic Pain; Female; Humans; Hydromorphone	2020
The thermal antinociceptive effects of a high-concentration formulation of buprenorphine alone or followed by hydromorphone in conscious cats. Veterinary anaesthesia and analgesia, 2021, Volume: 48, Issue:4 Topics: Analgesics; Analgesics, Opioid; Animals; Buprenorphine; Cats; Cross-Over Studies; Female; Hydromorphone	2021
Hydromorphone and codeine concentrations in oral fluid specimens from patients receiving substitution therapy with Substitol™ (morphine sulfate). Drug testing and analysis, 2021, Volume: 13, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Buprenorphine; Codeine; Female; Humans; Hydromorphone; Male; Methadone; Middle Aged; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Saliva; Substance Abuse Detection	2021
Declines and regional variation in opioid distribution by U.S. hospitals. Pain, 2022, 06-01, Volume: 163, Issue:6 Topics: Analgesics, Opioid; Buprenorphine; Codeine; Hospitals; Humans; Hydromorphone; Meperidine; Methadone; Morphine; Oxymorphone; United States	2022
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases. Journal of analytical toxicology, 2022, Oct-14, Volume: 46, Issue:8 Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem	2022
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder. Addiction science & clinical practice, 2023, 02-24, Volume: 18, Issue:1 Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Hydromorphone; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain	2023